verified SJR 1,045 · Q2 • database Scopus / SJR & Web of Science indexed

United Kingdom · Taylor and Francis Ltd.

workspace_premium Q2 — Gastroenterology lock Subscription Unclaimed

Expert Review of Gastroenterology and Hepatology

Expert Review of Gastroenterology and Hepatology is a journal indexed in SJR in Gastroenterology and Hepatology with an H index of 73. It has a price of 2083 €. It has an SJR impact factor of 1,045 and it has a best quartile of Q2. It has an SJR impact factor of 1,045.

ISSN: 1747-4124

Editorial: Taylor and Francis Ltd.

Category: Gastroenterology

Indexation: verifiedScopus / SJR verifiedWeb of Science

Unclaimed profile — some fields may be incomplete.

open_in_new Portal NPD menu_book Guidelines NPD

schedule Datos CoP · solo campos en BD

SJR Impact Factor trending_up

1,045 Q2

H-index 73

Tasa de Aceptación pie_chart

30% Selectiva

Fuente Acceptance_Rate

Tiempo a publicación hourglass_top

NPD

Campo Sin dato

Coste de Publicación (APC) payments

2.083 € Subscription

Ruta Non-OA 0 €

Metrics

Campos Scimago / CoP — sin series inventadas

Scopus / SJR Web of Science

SJR Impact

1,045

H-index

Docs (year)

Docs 3y

357

Total refs

6111

Cites 3y

1208

Citable 3y

336

Cites/Doc 2y

2.48

Ref/Doc

81.48

Immediate OA

2083 €

Embargoed OA

NPD

Non OA / Submission

0 €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Biomarkers for early diagnosis of pancreatic cancer

Who and how to screen for cancer in at-risk inflammatory bowel disease patients

Constipation assessment scales in adults: a literature review including the new Bowel Function Index

Concurrent nonalcoholic fatty liver disease and type 2 diabetes: diagnostic and therapeutic considerations

Comparison of endoscopic and surgical resection of intramucosal carcinoma in Barrett's esophagus

Colonoscopy: is it as effective as an advanced diagnostic tool for colorectal cancer screening?

Chronic diarrhea caused by idiopathic bile acid malabsorption: an explanation at last

Childhood constipation: finally something is moving!

Cells, cytokines and inflammatory bowel disease: a clinical perspective

Cell therapies for inflammatory bowel diseases

Cell death and nonalcoholic steatohepatitis: where is ballooning relevant?

Can we move towards personalised pancreatic cancer therapy?

SHOW MORE ARTICLES

Can micrometastases be used to predict colon cancer prognosis? Hopes for the EnRoute+ study

10th World Conference of the World Organization for Specialized Studies on Diseases of the Esophagus

Biliary atresia: how medical complications and therapies impact outcome

Artificial extracorporeal liver support therapy in patients with severe liver failure

Anti-TNF levels and anti-drug antibodies, immunosuppressants and clinical outcomes in inflammatory bowel disease

An update on the pathogenesis and clinical management of cirrhosis with refractory ascites

An update on the evaluation and management of iron deficiency anemia in inflammatory bowel disease

An overview of walled-off pancreatic necrosis for clinicians

An evaluation of entecavir for the treatment of chronic hepatitis B infection in adults

Adverse events in IBD therapy: the 2018 update

Advances in radiotherapy delivery for rectal cancer: a European perspective

Advances in liver regeneration

FAQS

In Country of Papers you can find SJR impact factor and other metrics to help you decide on a Journal.